Up

Arkema selects Singapore for the production of its Rilsan® high-performance bio-sourced polyamides

- Press release
Corporate - Finance - Products
Arkema has chosen the location of Jurong Island in Singapore to build its new world-scale plant dedicated to the manufacture of the amino 11 monomer and its flagship Rilsan® polyamide 11 resins. With this 50% increase in its global capacities announced in July 2017, the Group supports strong demand from its customers in Asia for high-performance bio-sourced solutions addressing the major opportunity of material lightweighting in particular.

Arkema has chosen the Jurong Island site in Singapore to set up its new bio-sourced polyamide production site. This location offers many advantages in terms of infrastructure, logistics, industrial integration and operational excellence, as well as optimization of the activity’s carbon footprint.

Use of 2-Octanol to make acrylates, maleates (green polymerization) and phtalates (plastic).

 

 

 

Rilsan® polyamide 11 is derived from castor oil and so is the only 100% bio-sourced polyamide approved for many of the most demanding applications, in particular in the electronics, 3D printing, oil and gas extraction, and automotive markets, as a substitute to metal.

This project is part of the Group’s exceptional investments totaling some 500 million euros earmarked for the 2018-2021 period essentially. Construction is scheduled to be completed by late 2021.

Contacts

Sophie FOUILLAT
Investor relations
Arie TAIEB
Investor relations
Gilles GALINIER
VP Communication
Arkema
Véronique OBRECHT
Corporate Press relations
Arkema
Contact